Implications of a formal diagnosis of BDUC6,21
| Advantages . | Disadvantages . |
|---|---|
| Registration at an HCC to provide access to expert clinical and diagnostic services | Excessive concern about bleeding risk with surgery, lifestyle, and sporting activities |
| Lifestyle advice about avoiding NSAID, monitoring HMB and iron deficiency | Uncertainty about the provisional diagnosis until further scientific advances are made |
| Appreciation of the problem for surgical bleeding risk/benefit | Additional health care cost and laboratory testing |
| Personalised management and patient preference | Delay in planning of surgery |
| Avoid unnecessary blood product use to treat hemorrhage | Unnecessary use of hemostatic agents and blood products |
| Awareness of the potential for bleeding in other family members | Potential unnecessary health and life insurance consequences |
| Defining a bleeding phenotype cohort for future research | Anxiety and guilt about the potential familial nature of the bleeding disorder |
| Avoiding anti-thrombotic therapies in people with established cardiovascular disease |
| Advantages . | Disadvantages . |
|---|---|
| Registration at an HCC to provide access to expert clinical and diagnostic services | Excessive concern about bleeding risk with surgery, lifestyle, and sporting activities |
| Lifestyle advice about avoiding NSAID, monitoring HMB and iron deficiency | Uncertainty about the provisional diagnosis until further scientific advances are made |
| Appreciation of the problem for surgical bleeding risk/benefit | Additional health care cost and laboratory testing |
| Personalised management and patient preference | Delay in planning of surgery |
| Avoid unnecessary blood product use to treat hemorrhage | Unnecessary use of hemostatic agents and blood products |
| Awareness of the potential for bleeding in other family members | Potential unnecessary health and life insurance consequences |
| Defining a bleeding phenotype cohort for future research | Anxiety and guilt about the potential familial nature of the bleeding disorder |
| Avoiding anti-thrombotic therapies in people with established cardiovascular disease |